Top compounds associated with response to OR4A47


Feature Type Standardized
Nominal ANOVA
mRNA ML162 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.024 0.4
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.026 0.4
mRNA tandutinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.026 0.4
mRNA nelarabine CTRPv2 pan-cancer AAC -0.031 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.029 0.4
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.027 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
Download CSV